Today's Family Medicine News Highlights

June 23, 2017

See mention of Dr. Francine Lemire in CMAJ News

Globe and Mail
Lower-risk cannabis-use guidelines to be released for safe use

Global News
Testing for Lyme disease needs to follow protocol in Saskatchewan, says Lyme Disease Foundation 
Access to electronic immunization records now available at point of care for First Nations communities in Alberta 

CFPC supports the Open Pharma initiative

Times Colonist
Groups in southern Alberta city seek approval of supervised safe injection site

Medical Post
Wireless sensor to remotely monitor heart implanted for first time in Canada


TORONTO | A medical team at the Peter Munk Cardiac Centre has implanted a wireless device inside a patient with heart failure that will allow clinicians to monitor the patient’s cardiovascular status remotely and in real time, and adjust treatment to prevent potentially unnecessary hospitalization.

It’s said to be the first time the device, known as the CardioMEM HF System, has been used in Canada.

The system incorporates a small, butterfly-like sensor that is placed inside the pulmonary artery and pillow device equipped with an antenna. When the patient lies on the pillow, the sensor transmits important clinical data, including lung pressure readings, via a secure website.

“Never before have we had the ability to obtain a patient’s accurate lung pressure data while they are outside the hospital,” says Meredith Linghorne, a nurse practitioner at the Peter Munk Cardiac Centre, part of University Health Network.

“Traditionally we’ve relied on a patient describing symptoms, and by then they may have already progressed to the point of hospitalization. With this device we can see warning signs days in advance, and adjust treatment accordingly.”

Funded by the Ted Rogers Centre for Heart Research, the device, produced by Abbott, was successfully implanted by interventional cardiologists in March 2017.

“Heart failure is an epidemic that commonly leads to hospitalization,” says Dr. Heather Ross, scientific lead at the Ted Rogers Centre for Heart Research and cardiologist at the Peter Munk Cardiac Centre.

“Hospitalization is often necessary when patients start to retain fluid, develop congestion and experience shortness of breath. This technology is a way to directly measure how much fluid is in a patient, allowing us to intervene before they develop symptoms of congestion, before they end up in hospital. This is a big game-changer.”

The new system, which is approved by the U.S. Food and Drug Administration and is awaiting approval by Health Canada, is designed to monitor heart failure patients whose condition is serious but who are not so ill that the technology cannot improve their outcome.

The first Canadian patient implanted with the heart monitor will be among 25 patients within the Ted Rogers Centre to be fitted with the device over the next nine months.

The incidence of heart failure is rising more rapidly than any other cardiovascular disease and now affects almost one million Canadians. Heart failure patients stay an average of almost 10 days for each hospital admission, accounting for 1.4 million hospital stays a year. About one-quarter of these patients return to hospital within three months, and approximately half of them are back in hospital within six months.

La Presse
Accord de principe avec les paramédicaux de Dolbeau-Mistassini 

Le Devoir
La résistance aux antibiotiques de certains organismes expliquée par des chercheurs 

Le Journal de Montréal
Recrutement de 150 médecins de la France envisagé par le Québec 
L’incidence de la démence chez les personnes âgées augmente dramatiquement au Canada 

Ici Radio-Canada
L’alcool causerait plus d’admissions à l’hôpital dans l’Ouest canadien 
OMS : Le bruit entraîne de plus en plus une perte de l’ouïe dans le monde - Audio

Copyright © 1996-2017 The College of Family Physicians of Canada